Sales and Marketing

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …

Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …

A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials …

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …

The spread of the Chinese coronavirus is accelerating, as multiple countries set up checks and tests to contain the virus. …

The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …

Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …